Profile
Vijay Chiruvolu worked as the Senior Vice President of Process Development at Kite Pharma, Inc. He then served as the Chief Technical Officer at Instil Bio, Inc. from 2020 to 2022.
In 2023, he became the Chief Technology Officer at Turnstone Biologics Corp.
Dr. Chiruvolu holds an MBA from The Pennsylvania State University and a doctorate degree from The University of Nebraska-Lincoln.
Former positions of Vijay Chiruvolu
| Companies | Position | End |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Chief Tech/Sci/R&D Officer | 2024-10-31 |
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 2022-09-01 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Training of Vijay Chiruvolu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nebraska-Lincoln
The University of Nebraska-Lincoln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Turnstone Biologics Corp.
Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Vijay Chiruvolu
















